John Libbey Eurotext



Stem cells and new french bioethics law Volume 18, issue 3, Mai-Juin 2012


See all figures

CNRS, UMR 7561, Biopôle, Campus Santé, 54505, Vandœuvre-lès-Nancy, France, CHU de Nancy, unité de thérapie cellulaire et tissus, 54511 Vandœuvre-lès-Nancy, France, Université de Lorraine, 54000 Nancy, France

In July 2011, the French bioethics law was the subject of a revision bringing few remarkable changes compared to the previous law, especially in the field of stem cells. Regarding Embryonic stem cells (ESC), the new law confirms the possibility to carry out research on the embryo and ESC exclusively after obtention of a derogation strictly regulated and delivered by the French Biomedicine Agency. On the other hand, the main advance of this law concerns a specific regulating of cord blood hematopoietic stem cells for therapeutic or scientific uses. This collection site is no longer considered as a medical waste but as a source of hematopoietic stem cells as well as bone marrow and peripheral blood.